All Issue

2020 Vol.1, Issue 2 Preview Page

Review article


March 2020. pp. 15-20
Abstract

Sorry, not available.
Click the PDF button.
References
1 

American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders : DSM-IV, 4th ed. Washington DC, American Psychiatric Association, 1994

2 

World Health Organization. International Classification of Diseases and Related Health Problems, 10th ed., Geneva, World Health Organization, 1994

3 

Serefoglu EC et al., An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation, J Sex Med, 2014

4 

Berkovitch M et al., Efficacy of Prilocaine-lidocaine cream in the treatment of premature ejaculation, J Urol, 1995

10.1097/00005392-199510000-000257658537
5 

Atikeler MK et al., Optimum usage of prilocaine-lidocaine cream in premature ejaculation, Andrologia, 2002

10.1046/j.1439-0272.2002.00511.x12472618
6 

Busato W et al., Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study, BJU Int, 2004

10.1111/j.1464-410X.2003.04773.x15142155
7 

Pu C et al., Topical anesthetic agents for premature ejaculation: A systematic review and meta-analysis, Urology, 2013

10.1016/j.urology.2012.12.02823434101
8 

Dinsmore et al., Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation, BJU Int, 2007

10.1111/j.1464-410X.2006.06583.x17129234
9 

Dinsmore WW et al., PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double-blind, placebo-controlled study, BJU Int, 2009

10.1111/j.1464-410X.2009.08456.x19245438
10 

Choi HK et al., Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study, Int J Impot Res, 1999

10.1038/sj.ijir.390043110553804
11 

Choi HK et al., Clinical study of SS-cream in patients with lifelong premature ejaculation, Urology, 2000

10.1016/S0090-4295(99)00415-X
12 

Martyn-St James M et al., Topical anaesthetics for premature ejaculation: A systematic review and meta- analysis, Sex Health, 2016

10.1071/SH1504226599522
13 

Waldinger MD et al., Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta- analysis, Int J Impot Res, 2004

10.1038/sj.ijir.390117214961051
14 

Waldinger MD et al., The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment, Psychopharmacology (Berl), 2002

10.1007/s00213-001-0980-311889497
15 

Safarinejad MR, Safety and efficacy of escitalopram in the treatment of premature ejaculation: A double blind, placebo-controlled, fixed-dose, randomized study, J Clin Psychopharmacol, 2007

10.1097/jcp.0b013e31814b98d417873675
16 

Zhang D et al. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis, BMC Urol, 2019

10.1186/s12894-018-0431-730606186PMC6318994
17 

Waldinger MD et al., On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment, Eur Urol, 2004

10.1016/j.eururo.2004.05.00515363569
18 

McMahon CG et al., Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies, J Urol, 1999

10.1097/00005392-199904010-00854
19 

Kim SW et al., Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: A randomized, double-blind, placebo- controlled, fixed-dose, parallel-grouped clinical study, Int J Impot Res, 2018

10.1038/s41443-017-0011-529203842
20 

Choi JB et al., Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: A multicenter, randomized, double-blind, phase III clinical trial, J Urol, 2019

10.1016/j.juro.2018.07.08930086277
21 

Modi NB et al., Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation, J Clin Pharmacol, 2006

10.1177/009127000528485016490806
22 

Giuliano F et al., Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: Comparison with paroxetine, J Urol, 2007

10.1016/j.juro.2006.08.07917162096
23 

Pryor JL et al., Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: An integrated analysis of two double-blind, randomised controlled trials, Lancet, 2006

10.1016/S0140-6736(06)69373-2
24 

Du Y et al., Efficacy and safety of "on-demand" dapoxetine in treatment of patients with premature ejaculation: a meta-analysis, Med Sci Monit, 2019

10.12659/MSM.91360631171764PMC6570993
25 

Martyn-St James M et al., Tramadol for premature ejaculation: a systematic review and meta-analysis, BMC Urol, 2015

10.1186/1471-2490-15-625636495PMC4417346
26 

Eassa BI et al., Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation, Asian J Androl, 2013

10.1038/aja.2012.9623103596PMC3739134
27 

Chen J et al., The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data, Eur Urol, 2007

10.1016/j.eururo.2007.08.00517728050
28 

Sun Y et al., Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis, Urology, 2015

10.1016/j.urology.2015.06.05126278825
29 

Martyn-St James M et al. Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis, Eur Urol Focus, 2017

10.1016/j.euf.2016.02.00128720356PMC5503121
30 

Sadeghi-Jejad H et al., Premature ejaculation: current medical treatment and new directions, J Sex Med, 2008

10.1111/j.1743-6109.2008.00831.x18439148
31 

Atan A et al., Comparison of the efficacy of fluoxetine alone vs. fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation, Arch Esp Urol, 2000

32 

Mills EJ et al., Demystifying trial networks and network meta-analysis, BMJ, 2013

10.1136/bmj.f291423674332
33 

Jian Z et al., Pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis, Int Urol Nephrol, 2018

10.1007/s11255-018-1984-930225547
34 

Sridharan K et al., Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials, Int J Impot Res, 2018.

10.1038/s41443-018-0030-x29921893
35 

Qin Z, Wang Y, Zhu J et al., Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a Bayesian network meta-analysis of randomized controlled trials, Int J Impot Res, 2019

10.1038/s41443-019-0146-731024113
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :2
  • Pages :15-20